Delisting risk
Lisata Therapeutics (LSTA)
Develops certepetide for tumor-penetrating cancer therapy combinations.
$1.57
At close0.00 (0.00%)
Something off on this page? Send us feedback.
Next report
Nov 5, 2026
in 63 days
EPS estimate
−$1.13
Revenue estimate
$659.0K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.55−$0.55−$0.54−$0.49−$0.33−$0.50−$0.32Pending
Estimate−$0.76−$0.53−$0.65−$0.54−$0.51——−$1.13
Surprise+27.6%−3.8%+16.9%+9.3%+35.3%———
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$1.0M—$70.0K—$100.0K——Pending
Estimate————$100.0K$94.4K—$659.0K
Surprise————0.0%———
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.13 | — | — |
| Aug 2026 | — | −$0.32 | — |
| May 2026 | — | −$0.50 | — |
| Mar 2026 | −$0.51 | −$0.33 | +35.3% |
| Nov 2025 | −$0.54 | −$0.49 | +9.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$1.13 | — | — | $659.0K | — | — | — |
| Aug 6, 2026 | — | −$0.32 | — | — | — | — | −4.5% |
| May 11, 2026 | — | −$0.50 | — | $94.4K | — | — | 0.0% |
| Mar 12, 2026 | −$0.51 | −$0.33 | +35.3% | $100.0K | $100.0K | 0.0% | 0.0% |
| Nov 6, 2025 | −$0.54 | −$0.49 | +9.3% | — | — | — | −12.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 9, 2024 | |||||||
| Feb 29, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Mar 22, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 13, 2020 | |||||||
| May 7, 2020 | |||||||
| Mar 5, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 9, 2019 | |||||||
| Mar 14, 2019 | |||||||
| Nov 8, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 10, 2018 | |||||||
| Mar 22, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 10, 2017 | |||||||
| May 15, 2017 | |||||||
| Mar 17, 2017 | |||||||
| Nov 7, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 5, 2016 | |||||||
| Mar 15, 2016 | |||||||
| Nov 5, 2015 | |||||||
| Aug 6, 2015 | |||||||